Literature DB >> 18976335

National study of emergency department visits for acute exacerbation of chronic obstructive pulmonary disease, 1993-2005.

Chu-Lin Tsai1, Justin A Sobrino, Carlos A Camargo.   

Abstract

OBJECTIVES: Little is known about recent trends in U.S. emergency department (ED) visits for acute exacerbation of chronic obstructive pulmonary disease (AECOPD) or about ED management of AECOPD. This study aimed to describe the epidemiology of ED visits for AECOPD and to evaluate concordance with guideline-recommended care.
METHODS: Data were obtained from National Hospital Ambulatory Medical Care Survey (NHAMCS). ED visits for AECOPD, during 1993 to 2005, were identified using the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes. Concordance with guideline recommendations was evaluated using process measures.
RESULTS: Over the 13-year study period, there was an average annual 0.6 million ED visits for AECOPD, and the visit rates for AECOPD were consistently high (3.2 per 1,000 U.S. population; P(trend) = 0.13). The trends in the use of chest radiograph, pulse oximetry, or bronchodilator remained stable (all P(trend) > 0.5). By contrast, the use of systemic corticosteroids increased from 29% in 1993-1994 to 60% in 2005, antibiotics increased from 14% to 42%, and methylxanthines decreased from 15% to <1% (all P(trend) < 0.001). Multivariable analysis showed patients in the South (vs. the Northeast) were less likely to receive systemic corticosteroids (odds ratio [OR] = 0.6; 95% confidence interval [CI] = 0.4 to 0.9).
CONCLUSIONS: The high burden of ED visits for AECOPD persisted. Overall concordance with guideline-recommended care for AECOPD was moderate, and some emergency treatments had improved over time.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18976335     DOI: 10.1111/j.1553-2712.2008.00284.x

Source DB:  PubMed          Journal:  Acad Emerg Med        ISSN: 1069-6563            Impact factor:   3.451


  9 in total

1.  Azithromycin for prevention of exacerbations of COPD.

Authors:  Richard K Albert; John Connett; William C Bailey; Richard Casaburi; J Allen D Cooper; Gerard J Criner; Jeffrey L Curtis; Mark T Dransfield; Meilan K Han; Stephen C Lazarus; Barry Make; Nathaniel Marchetti; Fernando J Martinez; Nancy E Madinger; Charlene McEvoy; Dennis E Niewoehner; Janos Porsasz; Connie S Price; John Reilly; Paul D Scanlon; Frank C Sciurba; Steven M Scharf; George R Washko; Prescott G Woodruff; Nicholas R Anthonisen
Journal:  N Engl J Med       Date:  2011-08-25       Impact factor: 91.245

2.  Research using emergency department-related data sets: current status and future directions.

Authors:  Jon Mark Hirshon; Margaret Warner; Charlene B Irvin; Richard W Niska; Daniel A Andersen; Gordon S Smith; Linda F McCaig
Journal:  Acad Emerg Med       Date:  2009-11       Impact factor: 3.451

3.  Improved care of acute exacerbation of chronic obstructive pulmonary disease in two academic emergency departments.

Authors:  Chu-Lin Tsai; Adit A Ginde; Phillip G Blanc; Carlos A Camargo
Journal:  Int J Emerg Med       Date:  2009-02-14

4.  The validity of using ICD-9 codes and pharmacy records to identify patients with chronic obstructive pulmonary disease.

Authors:  Colin R Cooke; Min J Joo; Stephen M Anderson; Todd A Lee; Edmunds M Udris; Eric Johnson; David H Au
Journal:  BMC Health Serv Res       Date:  2011-02-16       Impact factor: 2.655

5.  Exacerbations of chronic obstructive pulmonary disease.

Authors:  Christine Garvey; Gabriel Ortiz
Journal:  Open Nurs J       Date:  2012-02-10

6.  Emergency department antibiotic use for exacerbations of COPD.

Authors:  Aleksandr M Tichter; Grigory Ostrovskiy
Journal:  Open Access Emerg Med       Date:  2018-12-05

7.  Quantitative Evaluation of Chronic Obstructive Pulmonary Disease and Risk Prediction of Acute Exacerbation by High-Resolution Computed Tomography.

Authors:  Qifeng Hua; Guoping Chen; Yin Yang; Shaoyi Leng; Zhenzhen Zhao; Feng Bai; Xiaowei Hu; Liyan Qiu; Zhe Yu; Hongbin Zhang; Jiapei Shi; Qi Dai
Journal:  Evid Based Complement Alternat Med       Date:  2022-07-12       Impact factor: 2.650

8.  Utilization due to chronic obstructive pulmonary disease and its predictors: a study using the U.S. National Emergency Department Sample (NEDS).

Authors:  Jasvinder A Singh; Shaohua Yu
Journal:  Respir Res       Date:  2016-01-06

9.  A Machine-learning Approach to Forecast Aggravation Risk in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease with Clinical Indicators.

Authors:  Junfeng Peng; Chuan Chen; Mi Zhou; Xiaohua Xie; Yuqi Zhou; Ching-Hsing Luo
Journal:  Sci Rep       Date:  2020-02-20       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.